Sanofi to resolve roughly 5,000 Zantac lawsuits in U.S., Bloomberg says

Sanofi will settle approximately 5,000 lawsuits claiming the French company sold its Zantac heartburn medicine without warning that it could potentially cause cancer, Bloomberg’s Jef Feeley, Anna Edney, and Tim Loh report, citing people familiar with the deal. The agreement covers cases around the medicine in five states, including New York, Pennsylvania, and Illinois, the authors note.